CD209 and cancer: Previous reports have shown that DC-SIGN of dendritic cells plays crucial roles in anti-cancer immunity, specifically in the initial contact between dendritic cells and resting T lymphocytes [23] therefore, we focused on DC-SIGN (+) dendritic cells.